Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes.
与甘精胰岛素U100相比，德谷胰岛素U100在1型糖尿病患者中发生严重及有症状低血糖的风险较低。
Ann Transl Med. 2018 Feb;6(3):63. doi: 10.21037/atm.2017.12.28.
